MARIA COLTA: Open Payments
NPI 1912662651 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 94 payments from 36 companies in 2025. Trend: 2023 $831 · 2024 $2,145 · 2025 $2,177
Food & beverage: $2,177
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $327 |
| Merck Sharp & Dohme LLC | 7 | $192 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Incyte Corporation | 5 | $120 |
| Alexion Pharmaceuticals, Inc. | 4 | $109 |
| Janssen Biotech, Inc. | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| EMD Serono, Inc. | 3 | $65 |
| PUMA BIOTECHNOLOGY, INC. | 3 | $65 |
| PFIZER INC. | 3 | $57 |
Products named: KEYTRUDA, KISQALI, ULTOMIRIS, JAKAFI, IMFINZI, REBLOZYL, Fabhalta, PLUVICTO.
Industry payments across IL — which companies pay providers there.
